Research Articles on Tuberculosis from 1940 onwards

Drug resistance in Mycobacterium tuberculosis: molecular mechanisms challengingfluoroquinolones and pyrazinamide effectiveness.
Chest. 2015 Apr;147(4):1135-1143.
Pyrazinamide: the importance of uncovering the mechanisms of action in mycobacteria.
Expert Rev Anti Infect Ther. 2015 May;13(5):593-603.
Orofacial tuberculosis: Clinical manifestations, diagnosis and management
J Family Med Prim Care. 2015 Jul-Sep; 4(3): 335–341.
Clinical Manifestation and Risk Factors of Tuberculosis Infection in Malaysia: Case Study of a Community Clinic
Glob J Health Sci. 2015 Jul; 7(4): 110–120.
Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis.
Science. 2011 Sep 16;333(6049):1630-2.
Pyrazinamide: the importance of uncovering the mechanisms of action in mycobacteria.
https://app.dimensions.ai/discover/publication?and_facet_journal=jour.1032453
Pyrazinamide: a frontline drug used for tuberculosis. Molecular mechanism of action resolvedafter 50 years?
ChemMedChem. 2012 Apr;7(4):558-60.
A multiple genome analysis of Mycobacterium tuberculosis reveals specific novel genes and mutations associated with pyrazinamide resistance.
BMC Genomics. 2017 Oct 11;18(1):769.
Pyrazinamide and Pyrazinoic Acid Derivatives Directed to Mycobacterial Enzymes AgainstTuberculosis.
Curr Protein Pept Sci. 2016;17(3):213-9.
Varying effects of common tuberculosis drugs on enhancing clofazimine activity in vitro.
Emerg Microbes Infect. 2017 Apr 26;6(4):e28. doi: 10.1038/emi.2017.24.